Potential of CXCR4/CXCL12 chemokine axis in cancer drug delivery

Y Wang, Y Xie, D Oupický - Current pharmacology reports, 2016 - Springer
This review discusses the potential of CXCR4 chemokine receptor in the design of
anticancer and antimetastatic drug delivery systems. The role of CXCR4 in cancer …

Non-viral carriers for nucleic acids delivery: Fundamentals and current applications

S Shtykalova, D Deviatkin, S Freund, A Egorova… - Life, 2023 - mdpi.com
Simple Summary Gene therapy is one of the most promising approaches to treating various
inherited and acquired diseases by delivering genetic constructs into the cells and tissues of …

Polycondensed peptide carriers modified with cyclic RGD ligand for targeted suicide gene delivery to uterine fibroid cells

A Egorova, S Shtykalova, M Maretina, A Selutin… - International Journal of …, 2022 - mdpi.com
Suicide gene therapy was suggested as a possible strategy for the treatment of uterine
fibroids (UFs), which are the most common benign tumors inwomen of reproductive age. For …

Генитальный эндометриоз

МИ Ярмолинская, ЭК Айламазян - 2017 - elibrary.ru
В книге рассматриваются современные взгляды о роли генетических, эндокринных и
иммунологических факторов в патогенезе генитального эндометриоза, обсуждаются …

Peptide-Based Nanoparticles for αvβ3 Integrin-Targeted DNA Delivery to Cancer and Uterine Leiomyoma Cells

A Egorova, A Selutin, M Maretina, S Selkov, A Kiselev - Molecules, 2022 - mdpi.com
Uterine leiomyoma is the most common benign tumor of the reproductive system. Current
therapeutic options do not simultaneously meet the requirements of long-term efficiency and …

CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery

A Egorova, A Shubina, D Sokolov, S Selkov… - International journal of …, 2016 - Elsevier
The application of small interfering RNA (siRNA) for specific gene inhibition is a promising
strategy in gene therapy treatments. The efficient cellular delivery of therapeutic siRNA is a …

Characterization of iRGD-ligand modified arginine-histidine-rich peptides for nucleic acid therapeutics delivery to αvβ3 integrin-expressing cancer cells

A Egorova, A Selutin, M Maretina, S Selkov, V Baranov… - Pharmaceuticals, 2020 - mdpi.com
Efficient and specific delivery of nucleic acid (NA) therapeutics to tumor cells is extremely
important for cancer gene therapy. Various therapeutic strategies include delivery of DNA …

Anti-angiogenic treatment of endometriosis via anti-VEGFA siRNA delivery by means of peptide-based carrier in a rat subcutaneous model

A Egorova, M Petrosyan, M Maretina, N Balashova… - Gene Therapy, 2018 - nature.com
Abstract Development of gene therapy for endometriosis requires inhibition of
vascularization in endometrial lesions. We have previously developed CXCR4 receptor …

[HTML][HTML] Characterization of modified mesoporous silica nanoparticles as vectors for siRNA delivery

A Slita, A Egorova, E Casals, A Kiselev… - Asian journal of …, 2018 - Elsevier
Gene therapy using siRNA molecules is nowadays considered as a promising approach.
For successful therapy, development of a stable and reliable vector for siRNA is crucial. Non …

Arginine-rich cross-linking peptides with different SV40 nuclear localization signal content as vectors for intranuclear DNA delivery

M Bogacheva, A Egorova, A Slita, M Maretina… - Bioorganic & Medicinal …, 2017 - Elsevier
The major barriers for intracellular DNA transportation by cationic polymers are their toxicity,
poor endosomal escape and inefficient nuclear uptake. Therefore, we designed novel …